Current situation of cardiac rehabilitation construction in China 2022

Artificial heart is a complex implantable medical device, which is used to replace the pumping function of the heart and maintain blood circulation. The global artificial heart market has been growing steadily, and good clinical randomized controlled trials have also demonstrated the clinical application potential of artificial hearts, making the artificial heart market still show great growth potential. This industry research starts with the indications, structure, development history, market and mainstream products of artificial heart, and introduces the development of artificial heart industry in detail.

Second, the current situation of artificial heart industry

Recently, China Cardiovascular Health and Disease Report 202 1 was released in Beijing. The report shows that the incidence and mortality of cardiovascular diseases in China still rank first. It is estimated that there are 330 million cardiovascular patients in China, including 6.5438+0.3 million stroke, 6.5438+0.65438+0.39 million coronary heart disease, 8.9 million heart failure, 5 million cor pulmonale, 4.87 million atrial fibrillation, 2.5 million rheumatic heart disease and 2 million congenital heart disease.

According to the statistics of the Ministry of Health, there are currently 173 hospitals with organ transplant qualifications in China. Among them, there are 105 hospitals qualified for liver transplantation, 135 hospitals qualified for kidney transplantation, 57 hospitals qualified for heart transplantation, 43 hospitals qualified for lung transplantation, 44 hospitals qualified for pancreas transplantation and 47 hospitals qualified for small intestine transplantation.

According to incomplete statistics, there are about 600,000 patients with end-stage heart failure in urgent need of treatment every year in China, but the donors for heart transplantation are very scarce. Most patients with end-stage heart failure can't get the chance of heart transplantation, and they often die while waiting for transplantation, and some patients are not suitable for heart transplantation.